King's College London and global pharmaceutical company, GlaxoSmithKline (GSK), have formed a new five-year partnership to use AI to provide insight into why and how some patients respond to certain cancer treatments.
WHY IT MATTERS
The collaboration will use AI systems to build tools that will support clinical decision-making to help improve patient outcomes.
This move has resulted in the...
U.K. and U.S. residents who reported a loss of smell and taste into a COVID-19 symptom-tracker app more often tested positive for the infection, according to a study published yesterday in Nature.
The COVID Symptom Study app was developed by health technology company Zoe Global with help from King's College London and Massachusetts General Hospital. It launched in the U.K. and the U.S. in late...
This morning computer hardware company Nvidia announced that it was teaming up with Scripps Research Translational Institute to kick off a new collaboration focused on developing artificial intelligence and deep learning tools that will help analyze genomic and digital health sensor data. In addition to the tools developed, the partners plan on creating a new best practice resource guide.
The...
A small study recently published in Translational Psychiatry showed that people living with schizophrenia could use a video game paired with an MRI scanner to curb verbal hallucinations.
Specifically, researchers at King’s College London’s Institute of Psychiatry, Psychology, and Neuroscience found that after the training people with schizophrenia were able to better control the verbal region in...
The European Commission has formed a working group that will create guidelines to evaluate the accuracy and reliability of health app data. The group’s first meeting will be in March.
This initiative, the European Commission explained, is a follow up to a consultation announced in April 2014 that asked digital health companies and others for help in identifying ways to encourage and regulate...
